Table 3.
Baseline CAC Score and CAC Score Change of the Study Participants According to the 2004 ATP III and 2013 ACC/AHA Guidelines
| Statin‐Eligible by ATP‐III Guidelines | Statin‐Eligible by ACC/AHA Guidelines | |
|---|---|---|
| N (%) | 256 (20.5) | 681 (54.7) |
| Baseline CAC score | 3 (0–49) | 6 (0–70) |
| Last follow‐up CAC score | 15 (0–104) | 21 (0–131) |
| Baseline CAC score category | ||
| 0, n (%) | 110 (43.7) | 308 (45.2) |
| 1–100, n (%) | 106 (42.1) | 263 (38.6) |
| 101–300, n (%) | 25 (9.9) | 65 (9.5) |
| >300, n (%) | 11 (4.4) | 45 (6.6) |
| Follow‐up interval (years) | 2.9 (2.1–3.5) | 2.9 (2.0–3.5) |
ACC/AHA indicates American College of Cardiology/American Heart Association; ATP III, Adult Treatment Panel III; CAC, coronary artery calcification.
*Continuous variables with skewed distributions are expressed as the median (and interquartile range). Categorical variables are expressed as the percentage (%).